Bayer AG won support from US regulators for a menopause drug that’s expected to hit the market in November under the name of Lynkuet.
Share
Read more
Bloomberg - Where voices unite, stories flourish, and community thrives through open dialogue and meaningful connections.
Company
Trending
Categories
© Bloombergnews. All rights resereved